Oratz R - Search Results

1

Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma.

Oratz R, Hauschild A, Sebastian G, Schadendorf D, Castro D, Bröcker EB, Orenberg EK. Oratz R, et al. Melanoma Res. 2003 Feb;13(1):59-66. doi: 10.1097/00008390-200302000-00010. Melanoma Res. 2003. PMID: 12569286 Clinical Trial.

2

Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine.

Oratz R, Cockerell C, Speyer JL, Harris M, Roses D, Bystryn JC. Oratz R, et al. J Biol Response Mod. 1989 Aug;8(4):355-8. J Biol Response Mod. 1989. PMID: 2754436

3

A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687).

Hochster H, Oratz R, Ettinger DS, Borden E. Hochster H, et al. Among authors: oratz r. Invest New Drugs. 1998-1999;16(3):259-63. doi: 10.1023/a:1006110431250. Invest New Drugs. 1998. PMID: 10360606 Clinical Trial.

4

Elective radiation therapy for high-risk malignant melanomas.

Cooper JS, Chang WS, Oratz R, Shapiro RL, Roses DF. Cooper JS, et al. Among authors: oratz r. Cancer J. 2001 Nov-Dec;7(6):498-502. Cancer J. 2001. PMID: 11769862

5

Immunotherapy of malignant melanoma.

Oratz R, Bystryn JC. Oratz R, et al. Dermatol Clin. 1991 Oct;9(4):669-82. Dermatol Clin. 1991. PMID: 1718648 Review.

6

Survival with regional and distant metastases from cutaneous malignant melanoma.

Roses DF, Karp NS, Oratz R, Dubin N, Harris MN, Speyer J, Boyd A, Golomb FM, Ransohoff J, Dugan M, et al. Roses DF, et al. Among authors: oratz r. Surg Gynecol Obstet. 1991 Apr;172(4):262-8. Surg Gynecol Obstet. 1991. PMID: 2006449

7

Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.

Oratz R, Speyer JL, Wernz JC, Hochster H, Meyers M, Mischak R, Spitler LE. Oratz R, et al. J Biol Response Mod. 1990 Aug;9(4):345-54. J Biol Response Mod. 1990. PMID: 2395000

8

Use of vaccines in treatment of malignant melanoma.

Bystryn JC, Shapiro RL, Harris M, Roses DF, Oratz R. Bystryn JC, et al. Among authors: oratz r. Clin Dermatol. 1996 Jul-Aug;14(4):337-41. doi: 10.1016/0738-081x(96)00063-6. Clin Dermatol. 1996. PMID: 8862911 Free article. Review. No abstract available.

9

Phase II clinical trial of recombinant alpha 2b interferon and 13 cis retinoic acid in patients with metastatic melanoma.

Rosenthal MA, Oratz R. Rosenthal MA, et al. Among authors: oratz r. Am J Clin Oncol. 1998 Aug;21(4):352-4. doi: 10.1097/00000421-199808000-00007. Am J Clin Oncol. 1998. PMID: 9708632 Clinical Trial.

10

A comparison of survival rates for treatment of melanoma metastatic to the brain.

Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R. Stone A, et al. Among authors: oratz r. Cancer Invest. 2004;22(4):492-7. doi: 10.1081/cnv-200026387. Cancer Invest. 2004. PMID: 15565805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page